Author

T. Zabinski

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:mouse· 4 Research Focus:cell type annotation· 3 Research Focus:cell-cell communication· 1 Assay:CITE-seq· 1 Assay:flow cytometry· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

G. M. Lord· 3 shared J. F. Neves· 3 shared J.-H. Schroeder· 3 shared C. Moreira Heliodoro· 2 shared E. Read· 2 shared G. Beattie· 2 shared J. W. Lo· 2 shared R. Jenner· 2 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

G. M. Lord

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

CD90 is not constitutively expressed in functional innate lymphoid cells

J.-H. Schroeder, G. Beattie, J. W. Lo, T. Zabinski, R. Jenner, N. Powell, J. F. Neves, G. M. Lord

This study shows that CD90 is not consistently expressed on all functional innate lymphoid cells in the gut, with some subsets expressing low or no CD90.

bioRxiv · Dec 11, 2021Immunology

Sustained post-developmental T-bet expression is critical for the maintenance of type 1 innate lymphoid cells in vivo

J.-H. Schroeder, L. B. Roberts, K. Meissl, J. W. Lo, D. Hromadova, K. Hayes, T. Zabinski, E. Read, C. Moreira Heliodoro, R. Reis, J. K. Howard, R. K. Grencis, J. F. Neves, B. Strobl, G. M. Lord

This study shows that sustained T-bet expression is necessary for maintaining intestinal ILC1 in vivo, and ILC1 depletion protects against colitis, suggesting potential therapeutic targeting of T-bet for IBD treatment.

bioRxiv · Jun 5, 2021Immunology

T-bet fate mapping identifies a novel ILC1-ILC2 subset in vivo

J.-H. SCHROEDER, N. Garrido-Mesa, T. Zabinski, A. Gallagher, L. Campbell, L. Roberts, E. Stolarczyk, G. Beattie, J. Lo, A. Iseppon, C. Moreira Heliodoro, R. Reis, R. Jenner, P. Lavender, J. Howard, , G. Lord

The paper identifies a novel ILC1-ILC2 subset using T-bet fate mapping and shows its dependence on T-bet and cytokine expression capabilities.

bioRxiv · Aug 21, 2020 · PreprintImmunology

ILC1-derived TGFβ1 drives intestinal remodelling

G. M. Jowett, M. D. A. Norman, T. T. L. Yu, P. Rosell Arevalo, D. Hoogland, S. Lust, E. Read, E. Hamrud, N. J. Walters, U. Niazi, M. W. H. Chung, D. Marciano, O. S. Omer, T. Zabinski, D. Danovi, , E. Gentleman

The paper shows ILC1-derived TGFβ1 drives intestinal epithelial crypt expansion and extracellular matrix remodeling in co-cultured organoids.

bioRxiv · Apr 20, 2020Immunology